• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究少突胶质细胞连接蛋白:Cx32 与突变型或野生型 Cx47 的异源二聚体相互作用不会促进或调节缝隙连接功能。

Investigating oligodendrocyte connexins: Heteromeric interactions between Cx32 and mutant or wild-type forms of Cx47 do not contribute to or modulate gap junction function.

机构信息

Department of Neurology and Rehabilitation, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.

Department of Neurology, SUNY Downstate Medical Center, Brooklyn, New York, USA.

出版信息

Glia. 2021 Aug;69(8):1882-1896. doi: 10.1002/glia.23999. Epub 2021 Apr 9.

DOI:10.1002/glia.23999
PMID:33835612
Abstract

Oligodendrocytes express two gap junction forming connexins, connexin 32 (Cx32) and Cx47; therefore, formation of heteromeric channels containing both Cx47 and Cx32 monomers might occur. Mutations in Cx47 cause both Pelizaeus-Merzbacher-like disease Type 1 (PMLD1) and hereditary spastic paraparesis Type 44 (SPG44) and heteromer formation between these mutants and Cx32 may contribute to the pathogenesis of these disorders. Here, we utilized electrophysiological and antibody-based techniques to examine this possibility. When cells expressing both Cx32 and Cx47 were paired with cells expressing either Cx32 or Cx47, properties were indistinguishable from those produced by cells expressing homotypic Cx32 or Cx47 channels. Similarly, pairing cells expressing both Cx32 and Cx47 with cells expressing Cx30 or Cx43 produced channels indistinguishable from heterotypic Cx32/Cx30 or Cx47/Cx43 channels, respectively. The same assessments were performed on cells expressing Cx32 and four mutant forms of Cx47 (p.I33M associated with SPG44 or p.P87S, p.Y269D or p.M283T associated with PMLD1). None of these mutants showed a functional effect on Cx32. Immunostained cells co-expressing Cx32WT (wild type) and Cx47WT showed a Pearson correlation coefficient close to zero, suggesting that any overlap was due to chance. p.Y269D showed a statistically significant negative correlation with Cx32, suggesting that Cx32 and this mutant overlap less than expected by chance. Co-immunoprecipitation of Cx32 with Cx47WT and mutants show only very low levels of co-immunoprecipitated protein. Overall, our data suggest that interactions between PMLD1 or SPG44 mutants and Cx32 gap junctions do not contribute to the pathogenesis of these disorders.

摘要

少突胶质细胞表达两种间隙连接形成连接蛋白,连接蛋白 32(Cx32)和 Cx47;因此,可能会形成包含 Cx47 和 Cx32 单体的异源通道。Cx47 突变导致 Pelizaeus-Merzbacher 样疾病 1 型(PMLD1)和遗传性痉挛性截瘫 44 型(SPG44),这些突变体与 Cx32 形成的异源体形成可能导致这些疾病的发病机制。在这里,我们利用电生理和基于抗体的技术来研究这种可能性。当表达 Cx32 和 Cx47 的细胞与表达 Cx32 或 Cx47 的细胞配对时,其性质与表达同型 Cx32 或 Cx47 通道的细胞产生的性质无法区分。同样,将表达 Cx32 和 Cx47 的细胞与表达 Cx30 或 Cx43 的细胞配对产生的通道分别与异型 Cx32/Cx30 或 Cx47/Cx43 通道无法区分。对表达 Cx32 和 Cx47 的四种突变体(与 SPG44 相关的 p.I33M 或与 PMLD1 相关的 p.P87S、p.Y269D 或 p.M283T)的细胞进行了相同的评估。这些突变体均未对 Cx32 产生功能影响。共表达 Cx32WT(野生型)和 Cx47WT 的免疫染色细胞的 Pearson 相关系数接近零,表明任何重叠都是偶然的。p.Y269D 与 Cx32 呈统计学上显著的负相关,表明 Cx32 和该突变体的重叠比偶然预期的要少。Cx32 与 Cx47WT 和突变体的共免疫沉淀显示仅存在非常低水平的共免疫沉淀蛋白。总体而言,我们的数据表明,PMLD1 或 SPG44 突变体与 Cx32 间隙连接之间的相互作用不会导致这些疾病的发病机制。

相似文献

1
Investigating oligodendrocyte connexins: Heteromeric interactions between Cx32 and mutant or wild-type forms of Cx47 do not contribute to or modulate gap junction function.研究少突胶质细胞连接蛋白:Cx32 与突变型或野生型 Cx47 的异源二聚体相互作用不会促进或调节缝隙连接功能。
Glia. 2021 Aug;69(8):1882-1896. doi: 10.1002/glia.23999. Epub 2021 Apr 9.
2
Mechanisms of Diseases Associated with Mutation in GJC2/Connexin 47.与 GJC2/Connexin 47 突变相关疾病的发病机制。
Biomolecules. 2023 Apr 21;13(4):712. doi: 10.3390/biom13040712.
3
Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins.两种不同的异型通道介导星形胶质细胞和少突胶质细胞连接蛋白之间的间隙连接偶联。
J Neurosci. 2007 Dec 19;27(51):13949-57. doi: 10.1523/JNEUROSCI.3395-07.2007.
4
The distribution and functional properties of Pelizaeus-Merzbacher-like disease-linked Cx47 mutations on Cx47/Cx47 homotypic and Cx47/Cx43 heterotypic gap junctions.Pelizaeus-Merzbacher-like 病相关连接蛋白 47 突变在连接蛋白 47/47 同源型和连接蛋白 47/43 异型缝隙连接上的分布和功能特性。
Biochem J. 2013 Jun 1;452(2):249-58. doi: 10.1042/BJ20121821.
5
Activation of the unfolded protein response by Connexin47 mutations associated with Pelizaeus-Merzbacher-like disease.连接蛋白 47 突变相关的 Pelizaeus-Merzbacher-like 病中未折叠蛋白反应的激活。
Mol Cell Neurosci. 2022 May;120:103716. doi: 10.1016/j.mcn.2022.103716. Epub 2022 Mar 8.
6
Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice.星形胶质细胞连接蛋白Cx26、Cx30、Cx43与少突胶质细胞连接蛋白Cx29、Cx32、Cx47的偶联:来自正常小鼠和连接蛋白32基因敲除小鼠的启示
Glia. 2003 Dec;44(3):205-18. doi: 10.1002/glia.10278.
7
Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions.在转基因小鼠中敲除Cx47会导致少突胶质细胞-星形胶质细胞缝隙连接处的MUPP1、ZONAB和多种连接蛋白缺失。
Eur J Neurosci. 2008 Oct;28(8):1503-17. doi: 10.1111/j.1460-9568.2008.06431.x.
8
Cx32 and Cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte:oligodendrocyte gap junction coupling.缝隙连接蛋白 32 和 47 介导少突胶质细胞-星形胶质细胞和少突胶质细胞-少突胶质细胞缝隙连接耦联。
Neurobiol Dis. 2011 Jun;42(3):506-13. doi: 10.1016/j.nbd.2011.03.003. Epub 2011 Mar 8.
9
Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.遗传性痉挛性截瘫是GJA12/GJC2突变的一种新表型。
Brain. 2009 Feb;132(Pt 2):426-38. doi: 10.1093/brain/awn328. Epub 2008 Dec 4.
10
Connexin47, connexin29 and connexin32 co-expression in oligodendrocytes and Cx47 association with zonula occludens-1 (ZO-1) in mouse brain.连接蛋白47、连接蛋白29和连接蛋白32在小鼠脑少突胶质细胞中的共表达以及连接蛋白47与紧密连接蛋白1(ZO-1)的关联
Neuroscience. 2004;126(3):611-30. doi: 10.1016/j.neuroscience.2004.03.063.

引用本文的文献

1
Mechanisms of Diseases Associated with Mutation in GJC2/Connexin 47.与 GJC2/Connexin 47 突变相关疾病的发病机制。
Biomolecules. 2023 Apr 21;13(4):712. doi: 10.3390/biom13040712.